Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
9
|
pubmed:dateCreated |
1986-3-5
|
pubmed:abstractText |
A quantitative method for circulating islet cell surface antibodies (ICSA), based on the binding of 125I-protein A to insulin-producing RINm5F cells, was used to evaluate ICSA in plasma of 4- to 40-week-old Aston obese hyperglycaemic (ob/ob) mice and normal control (+/+) mice. RINm5F cells bound 2502 +/- 1196 c.p.m. 125I-protein A per 10(5) cells (mean +/- S.D., n = 54) after incubation with +/+ plasma. ICSA positive plasma (defined as 125I-protein A binding, mean +/- 2 S.D. of +/+ plasma) was detected in 3 out of 54 +/+ mice and 3 out of 54 ob/ob mice. ICSA were not observed in ob/ob mice before the onset of diabetes (7 weeks of age), but were detected at 9, 20 and 40 weeks. At 20 weeks 125I-protein A binding produced by ob/ob plasma was 35% greater than +/+ plasma (P less than 0.05). The low occurrence of ICSA in ob/ob mice (6%) suggests that factors other than ICSA are responsible for B-cell dysfunction and eventual islet degeneration observed in Aston ob/ob mice.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Sep
|
pubmed:issn |
0144-8463
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
5
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
715-20
|
pubmed:dateRevised |
2003-11-14
|
pubmed:meshHeading |
pubmed-meshheading:3910131-Aging,
pubmed-meshheading:3910131-Animals,
pubmed-meshheading:3910131-Antigens, Surface,
pubmed-meshheading:3910131-Autoantibodies,
pubmed-meshheading:3910131-Diabetes Mellitus, Experimental,
pubmed-meshheading:3910131-Hyperglycemia,
pubmed-meshheading:3910131-Islets of Langerhans,
pubmed-meshheading:3910131-Mice,
pubmed-meshheading:3910131-Mice, Obese
|
pubmed:year |
1985
|
pubmed:articleTitle |
Islet cell surface antibodies in genetically obese hyperglycaemic (ob/ob) mice.
|
pubmed:publicationType |
Journal Article
|